Vaxart's bivalent norovirus vaccine candidate has many broad advantages

preview_player
Показать описание
Vaxart CMO Dr. James Cummings details the broad advantages of Vaxart's bivalent norovirus oral pill vaccine candidate, during the company's recent Q1 2023 conference call.
  1. Vaxart
Рекомендации по теме
$VXRT stock Due 0:11:37

$VXRT stock Due Diligence & Technical analysis - Stock overview (5th update)

VAXART: GAME CHANGER 0:11:02

VAXART: GAME CHANGER 🎯 COVID-19 PILL | Is VAXART a BUY ? | VXRT | 10x Stock 🔥 | Late Night Stocks...

Is Vaxart a 0:08:15

Is Vaxart a BUY?

VXRT Vaxart Stock 0:16:07

VXRT Vaxart Stock is up 142% | Huge Growth Stock Analysis | 3X your money | Price prediction

New Wind Turbine 0:15:56

New Wind Turbine Penny stock under 1 Euro HUGE Potential. Vaxart VXRT Full analysis. BUY the DIP.